<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Advances in medicine &#187; Main</title>
	<atom:link href="http://www.advances-in-medicine.com/category/main/feed" rel="self" type="application/rss+xml" />
	<link>http://www.advances-in-medicine.com</link>
	<description></description>
	<lastBuildDate>Fri, 16 Jul 2010 17:18:10 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Pharmacy Benefit Decisions: DISCUSSION</title>
		<link>http://www.advances-in-medicine.com/2010/07/pharmacy-benefit-decisions-discussion.html</link>
		<comments>http://www.advances-in-medicine.com/2010/07/pharmacy-benefit-decisions-discussion.html#comments</comments>
		<pubDate>Fri, 16 Jul 2010 17:18:10 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[Benefit Decisions]]></category>
		<category><![CDATA[Pharmacy]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=1984</guid>
		<description><![CDATA[
These results are exploratory and are limited by the small number of participants and managed care organizations represented. No attempt was made to obtain a random or representative sample of managed care decision-makers, so the findings cannot be generalized beyond the study participants. However, a number of the findings are consistent with results reported by [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/07/pharmacy-benefit-decisions-discussion.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmacy Benefit Decisions: RESULTS</title>
		<link>http://www.advances-in-medicine.com/2010/07/pharmacy-benefit-decisions-results.html</link>
		<comments>http://www.advances-in-medicine.com/2010/07/pharmacy-benefit-decisions-results.html#comments</comments>
		<pubDate>Thu, 15 Jul 2010 17:18:09 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[Benefit Decisions]]></category>
		<category><![CDATA[Pharmacy]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=1983</guid>
		<description><![CDATA[To obtain the target of 10 focus group participants, 29 prospective participants from the conference pre-registrant list were identified and contacted. Although eight men and three women met the inclusion criteria and agreed to participate, three of them were unable to attend, leaving a total of eight (i.e., six men and two women) focus group [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/07/pharmacy-benefit-decisions-results.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmacy Benefit Decisions: METHODS</title>
		<link>http://www.advances-in-medicine.com/2010/07/pharmacy-benefit-decisions-methods.html</link>
		<comments>http://www.advances-in-medicine.com/2010/07/pharmacy-benefit-decisions-methods.html#comments</comments>
		<pubDate>Wed, 14 Jul 2010 17:18:09 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[Benefit Decisions]]></category>
		<category><![CDATA[Pharmacy]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=1982</guid>
		<description><![CDATA[To fulfill the research objectives, two focus groups with five participants each were planned. Potential participants were identified, based on their job titles, from among pre-registrants of a conference sponsored by the University of Arizona&#8217;s Center for Health Outcomes and PharmacoEconomic Research. They were contacted by telephone to determine interest in participation and eligibility. Specific [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/07/pharmacy-benefit-decisions-methods.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmacy Benefit Decisions</title>
		<link>http://www.advances-in-medicine.com/2010/07/pharmacy-benefit-decisions.html</link>
		<comments>http://www.advances-in-medicine.com/2010/07/pharmacy-benefit-decisions.html#comments</comments>
		<pubDate>Tue, 13 Jul 2010 17:24:21 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[Benefit Decisions]]></category>
		<category><![CDATA[Pharmacy]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=1981</guid>
		<description><![CDATA[
The pattern of illness in the U.S. has shifted from mostly acute disease to one in which chronic conditions predominate. Although there are many diseases that can shorten life expectancy, it is more likely that a disease will have adverse health consequences that result in dysfunction and decreased well-being. Hence, patient self-reports of functioning and [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/07/pharmacy-benefit-decisions.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Just the Facts</title>
		<link>http://www.advances-in-medicine.com/2010/07/just-the-facts.html</link>
		<comments>http://www.advances-in-medicine.com/2010/07/just-the-facts.html#comments</comments>
		<pubDate>Thu, 08 Jul 2010 15:55:14 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[Facts]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=1967</guid>
		<description><![CDATA[Dozens of times each day, drug information specialists at Thomas Jefferson University Hospital (TJUH) contact physicians to suggest changes in their pharmaceutical product-related orders. These can be minor changes, such as sorting out misspellings, or they might be potentially life-saving changes, as in correcting the dose of an aminoglycoside, or alerting a physician to a [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/07/just-the-facts.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>After Baycol, Now What: part 2</title>
		<link>http://www.advances-in-medicine.com/2010/07/after-baycol-now-what-part-2.html</link>
		<comments>http://www.advances-in-medicine.com/2010/07/after-baycol-now-what-part-2.html#comments</comments>
		<pubDate>Wed, 07 Jul 2010 15:55:13 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[Baycol]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=1966</guid>
		<description><![CDATA[Modifications of the lipid and lipoprotein classification now identify LDL cholesterol below 100 mg/dl as optimal. What is now considered to be low HDL cholesterol has changed to values below 40 mg/dl, up from the previous 35 mg/dl. The optimal triglyceride level has been determined to be less than 150 mg/dl. The new guidelines suggest [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/07/after-baycol-now-what-part-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>After Baycol, Now What</title>
		<link>http://www.advances-in-medicine.com/2010/07/after-baycol-now-what.html</link>
		<comments>http://www.advances-in-medicine.com/2010/07/after-baycol-now-what.html#comments</comments>
		<pubDate>Tue, 06 Jul 2010 16:04:45 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[Baycol]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=1965</guid>
		<description><![CDATA[
The withdrawal of cerivastatin (Baycol, Bayer) from the market for safety reasons posed a huge problem for P&#38;T committees and all members of the health care team who uphold the safety of patients. It came in the face of a worldwide evolution to modern lifestyles that in the aggregate involve decreased exercise levels with a consequential [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/07/after-baycol-now-what.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
